Wearable-supported exercise guidance may improve walking capacity in type 2 diabetes
Key takeaway:
In outpatients with type 2 diabetes, wearable-supported monthly physiotherapist exercise guidance improved walking distance and HbA1c over six months compared with standard care.
Study at a glance
What was studied
Wearable-supported physiotherapist exercise guidance for outpatients with type 2 diabetes.
Study type
non-randomized clinical trial (non-RCT or NRCT)
duration
Medium-Term (3–12 mo)
Intervention
Exercise therapy
Outcomes
6-minute walk distance, HbA1c, Weight-bearing index, Phase angle, Estimated glomerular filtration rate, Adverse events incidence
Funding
Non-industry sponsored
Main effects
↑ 6-minute walk distance: adjusted between-group change +42.4 m at six months
↓ HbA1c: greater reduction in the intervention group than standard care
↔ eGFR: no clear short-term kidney filtration effect
Evidence Summary
| Intervention | Outcome | Measured Change | Study Effect |
|---|---|---|---|
 Exercise therapy (Physical Activity) |  6-minute walk distance (Clinical Outcomes) | Increase | Strong |
Exercise therapy (Physical Activity) |  Adverse events incidence (Safety) | Uncertain | Limited |
Exercise therapy (Physical Activity) | Estimated glomerular filtration rate (Clinical Outcomes) | Uncertain | Limited |
Exercise therapy (Physical Activity) |  HbA1c (Glycemic Control) | Decrease | Mixed |
Exercise therapy (Physical Activity) |  Phase angle (Metabolic Health) | Increase | Mixed |
Exercise therapy (Physical Activity) | Weight-bearing index (Metabolic Health) | Increase | Mixed |
Unlock Full Evidence Analysis
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Evidence Suggest
- The intervention group improved 6MWD from 512.0 m to 551.0 m, while the comparison group changed from 410.0 m to 407.0 m.
- HbA1c decreased more in the intervention group, with an adjusted between-group difference of -0.89 percentage points.
- No intervention-related adverse events, severe hypoglycemia, injurious falls, musculoskeletal withdrawals, or attributable cardiovascular events were reported.
Who this applies to
Adults with type 2 diabetes in outpatient care.
Keep in Mind
This was not clearly randomized based on the available excerpts.
Between the Lines
- Small single-center study with 45 per-protocol completers.
- Allocation is described, but randomization is not clearly reported in the excerpts.
- Secondary outcomes were exploratory and not formally adjusted for multiple comparisons.
- Follow-up was limited to six months.
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Journal Reference
Physiotherapist-guided, wearable-informed exercise improves 6-minute walk distance in patients with type 2 diabetes, including those with diabetic kidney disease: a prospective study. Diabetol Int. Published April 22, 2026. doi:10.1007/s13340-026-00900-x
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.